Regent Pacific Announces Important Commercialisation Progress On FORTACIN(TM) / SENSTEND(TM)

PR Newswire


MAINLAND CHINA

  • Regent Pacific to receive a total payment of US$4 million upon the receipt of approval from the National Medical Products Administration (NMPA) for conducting human trial
  • China is expected to be the single largest market for Sendstend™



UNITED STATES

  • The Phase II validation study of Fortacin™ in the US and submission to the FDA are expected to complete by the end of 2020 and first half of 2021 respectively
  • The pivotal Phase III study in US is expected to commence in late 2021



TAIWAN, HONG KONG, MACAU

  • Approval from the Taiwan FDA is expected in early 2021
  • Fortacin™ is expected to launch in Hong Kong and Macau in 2021

HONG KONG, Nov. 17, 2020 /PRNewswire/ — Regent Pacific Group Limited (“Regent Pacific” or the “Company” and together with its subsidiaries, the “Group”; stock code: 0575.HK), a specialist healthcare, wellness and life sciences investment group is pleased to announce several important commercialisation progress on SENSTEND™ (the marketing name of FORTACIN™ in mainland China), the first prescription treatment for treating premature ejaculation (PE) in mainland China, US, Taiwan, Hong Kong and Macau respectively.


Accelerates the participation in the potentially single largest market for Senstend™

The investigational new drug (IND) for Clinical Trial Approval (CTA) has been submitted to the Center of Drug Evaluation of the National Medical Products Administration by  Wanbang Pharmaceutical Marketing and Distribution Co., Ltd. (“Wanbang Pharmaceutical”), a wholly controlled company of Shanghai Fosun Pharma, Regent Pacific’s commercial strategic partner in China to seek marketing approval of Senstend™ in China. It is expected that the approval would be obtained by the end of Q1 2021. Upon receiving the approval, Regent Pacific will receive a total payment of US$4 million (approximately HK$30 million) from Wanbang Pharmaceutical as per the terms of the licence agreement. The payment will be divided into two terms, US$800,000 (approximately HK$6.24 million) will be received upon the approval from NMPA to submit IND application for human clinical trial of a licensed product at NMPA. The remaining US$3.20 million (HK$24.96 million) will be received upon the receipt of the approval from the NMPA to conduct a human clinical trial of a licensed product or written NMPA acceptance as sufficient of provided data without need for conducting a further clinical trial.


Crucial step towards acquiring necessary regulatory approvals in the United States

In the United States, The Phase II validation study of Fortacin™ by the U.S. Food and Drug Administration (“US FDA”) is expected to be completed by the end of 2020, followed by the submission to the FDA in the first half of 2021. The pivotal Phase III study is expected to commence in the latter half of 2021, with New Drug Application (“NDA”) submission possible in late 2022, giving a Prescription Drug User Fee Act date at the end of 2023 and contribute to the acquisition of all necessary regulatory approvals needed to commercialise Fortacin™ in the United States.


Steady progress in Taiwan, Hong Kong and Macau

In Taiwan, the Taiwan FDA (“TFDA”) has recently approved the Drug Master Files for lidocaine and prilocaine, the active pharmaceutical ingredients of Fortacin™; and also, the plant master file application for the manufacturer of Fortacin™. It is anticipated that the approval could be obtained from TFDA by early 2021 which will trigger a payment of US$300,000 (or approximately HK$2.34 million) to the Group.

In addition, Fortacin™ is expected to be launched in Hong Kong and Macau in 2021, a delay as a result of the COVID-19 pandemic which significantly affected the number of orders.


Product sales in the European market gradually resume to normal despite the impact of COVID-19 continues

Since Regent Pacific’s European marketing and distribution partner for Fortacin™ is based in Italy, it has been affected by the COVID-19 pandemic. During Q3 2020, the European markets continued to be affected by the pandemic due both to the restrictions imposed to limit contagion in all territories, as well as from a cautious management of stocks by wholesalers. It is expected that the COVID-19 pandemic will continue to affect sales inQ4 2020, but with the sales activities gradually resuming to normal in the latter half of 2021. Necessary measures have been adopted so that the production and distribution activities of the product would not be affected.


Jamie Gibson, Chief Executive Officer of Regent Pacific
, said, “We are glad to witness that Fortacin™ / Sendstend™ has received remarkable progress in different markets despite the impacts of the COVID-19 pandemic. We will continue to work closely and diligently with our current and prospective commercial partners and will keep shareholders and potential investors informed of any new developments as and when they occur.”

This press release is distributed by LBS Communications Consulting Limited.

About Regent Pacific

Regent Pacific is a diversified investment group based in Hong Kong currently holding various corporate and strategic investments focusing on the healthcare, wellness and life sciences sectors. The Group has a strong track record of investments and has returned approximately US$298 million to shareholders in the 21 years of financial reporting since its initial public offering in May 1997. 

About Fortacin™ / Sendstend™

Fortacin™ / Sendstend™ is the first solution to premature ejaculation (PE) that does not act on the central nervous system and offers bona fide therapeutic efficacy that has been validated through extensive clinical trials in Europe, with over 23,500 doses delivered to trial participants. The solution is a topical spray containing low doses of lidocaine and prilocaine that take effect almost immediately upon application, giving users more control without reducing pleasure. Fully approved by the European Medicines Agency (EMA), Fortacin™ is now available in France, Germany, Italy, Portugal, Spain and the UK.

Cision View original content:http://www.prnewswire.com/news-releases/regent-pacific-announces-important-commercialisation-progress-on-fortacintm–senstendtm-301175471.html

SOURCE Regent Pacific Group Limited

Fuse Medical, Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update in Response to COVID-19

Fuse Medical, Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update in Response to COVID-19

RICHARDSON, Texas–(BUSINESS WIRE)–
Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) announced that it filed its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2020 with the Securities and Exchange Commission (“SEC”) on Monday, November 16, 2020.

Third Quarter 2020 Highlights

  • Revenue for the third quarter of 2020 was approximately $5.7 million, up 43% from the second quarter 2020, and an approximate $22,000 increase when compared to the prior-year period
  • Gross profit for the third quarter of 2020 was 64.4% of revenue, compared to 16.2% of revenue for the prior-year period
  • Operating expenses for the third quarter of 2020 were 24.0% of revenues, compared to 39.6% of revenues for the prior-year period
  • Net income in the third quarter of 2020 was approximately $80,000, compared to a net loss of approximately $4.1 million for the prior-year period

Chief Executive Officer, Christopher C. Reeg said, “We are very pleased with our results for the third quarter of 2020, especially in light of the impact the COVID-19 pandemic continues to have on our industry and economy overall. We believe the success of our third quarter is driven largely by our strong focus on revenues and customers, as well as the results of our implementation of strategic expense reduction introduced in the first half of 2020. These positive results reflect the momentum and hard work of the entire Fuse team who’s dedication remains vigilant as we continue to navigate these uncertain times. We look forward to keeping these positive trends as we finish out the fourth quarter.”

The Quarterly Report on Form 10-Q filing can be viewed in the “Investors” section of the Company’s website, www.fusemedical.com as well as the SEC’s website.

About Fuse Medical, Inc.

Fuse is an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace. We provide a comprehensive portfolio of products in the orthopedic total joints, sports medicine, trauma, foot and ankle space, as well as, degenerative and deformity spine, orthobiologics and regenerative medicine products. For more information about the Company, or if you’re interested in becoming a distributor of any Fuse’s products, please contact us at [email protected] or visit: www.fusemedical.com.

Forward Looking Statements

Certain statements in this press release, constitute “forward-looking statements” within the meaning of the federal securities laws. Words such as “may,” “might,” “will,” “should,” “believe,” “expect,” “anticipate,” “estimate,” “continue,” “predict,” “forecast,” “project,” “plan,” “intend,” or similar expressions or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based only on information available to the Company as of the date of this release. These forward-looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including, without limitation, those set forth in the Company’s filings with the Securities and Exchange Commission; the failure of the Company to close the transaction; and integration issues with the consolidated company. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events, or otherwise, except as required by law.

Fuse Medical, Inc.

Devon Morgan, Sr. Investor Relations Analyst

Office (469) 862-3030

Facsimile (469) 862-3035

[email protected]

KEYWORDS: Texas United States North America

INDUSTRY KEYWORDS: Surgery Medical Devices Hospitals Biotechnology Other Health Physical Therapy Managed Care Health General Health

MEDIA:

WeissLaw LLP Reminds BSTC, DNKN, NAV, and PNM, Shareholders About Its Ongoing Investigations

PR Newswire

NEW YORK, Nov. 17, 2020 /PRNewswire/ —


If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:


Joshua Rubin, Esq.

WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY  10036
(212) 682-3025
(888) 593-4771
[email protected]

BioSpecifics Technologies Corp. (NASDAQ: BSTC)

URGENT – TENDER OFFER EXPIRES DECEMBER 1, 2020

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of BioSpecifics Technologies Corp. (NASDAQ: BSTC) in connection with the proposed acquisition of the company via tender offer by Endo International plc.  Under the terms of the tender offer, BSTC shareholders will receive $88.50 in cash for each share of BSTC common stock that they own.  If you own BSTC shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website:  https://weisslawllp.com/bstc/ 

Dunkin’ Brands Group, Inc. (NASDAQ: DNKN)

URGENT – TENDER OFFER EXPIRES DECEMBER 14, 2020

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Dunkin’ Brands Group, Inc. (NASDAQ: DNKN) in connection with the proposed acquisition of the company by Inspire Brands, Inc.  Under the terms of the acquisition agreement, which is structured as a tender offer, DNKN shareholders will receive $106.50 in cash for each share of DNKN common stock that they own.  If you own DNKN shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website:  https://weisslawllp.com/dnkn/ 

Navistar International Corporation (NYSE: NAV)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Navistar International Corporation (NYSE: NAV) in connection with the proposed acquisition of the company by TRATON SE (“TRATON”).  Under the terms of the acquisition agreement, TRATON, which already controls 16.7% of NAV common stock, will acquire all outstanding shares of NAV that it does not already own, and NAV shareholders will receive $44.50 in cash for each share of NAV that they hold.  If you own NAV shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/NAV/ 

PNM Resources, Inc. (NYSE: PNM)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of PNM Resources, Inc. (NYSE: PNM) in connection with the proposed acquisition of the company by Avangrid, Inc.  Under the terms of the acquisition agreement, PNM shareholders will receive $50.30 in cash for each share of PNM common stock that they own.  If you own PNM shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website:https://weisslawllp.com/pnm/  

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/weisslaw-llp-reminds-bstc-dnkn-nav-and-pnm-shareholders-about-its-ongoing-investigations-301175449.html

SOURCE WeissLaw LLP

HD SUPPLY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of HD Supply Holdings, Inc. – HDS

HD SUPPLY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of HD Supply Holdings, Inc. – HDS

NEW ORLEANS–(BUSINESS WIRE)–
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of HD Supply Holdings, Inc. (NasdaqGS: HDS) to The Home Depot, Inc. (NYSE: HD). Under the terms of the proposed transaction, shareholders of HD Supply will receive only $56.00 in cash for each share of HD Supply that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ([email protected]) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqgs-hds/ to learn more.

Please note that the merger is structured as a tender offer, such that time may be of the essence.

To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.

Kahn Swick & Foti, LLC

1100 Poydras St., Suite 3200

New Orleans, LA 70163

Kahn Swick & Foti, LLC

Lewis S. Kahn, 855-768-1857

Managing Partner

[email protected]

KEYWORDS: United States North America Louisiana

INDUSTRY KEYWORDS: Legal Professional Services

MEDIA:

Logo
Logo

UROVANT SCIENCES INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Urovant Sciences – UROV

UROVANT SCIENCES INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Urovant Sciences – UROV

NEW ORLEANS–(BUSINESS WIRE)–
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Urovant Sciences (NasdaqGS: UROV) to Sumitovant Biopharma. Under the terms of the proposed transaction, shareholders of Urovant will receive only $16.25 in cash for each share of Urovant that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ([email protected]) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqgs-urov/ to learn more.

To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.

Kahn Swick & Foti, LLC

Lewis S. Kahn, 855-768-1857

KSF Managing Partner

[email protected]

KEYWORDS: Louisiana United States North America

INDUSTRY KEYWORDS: Legal Professional Services

MEDIA:

Logo
Logo

SHAREHOLDER ALERT: WeissLaw LLP Reminds STND, LOAK, MCAC, and LFAC Shareholders About Its Ongoing Investigations

PR Newswire

NEW YORK, Nov. 17, 2020 /PRNewswire/ —


If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:


Joshua Rubin, Esq.

WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY  10036
(212) 682-3025
(888) 593-4771
[email protected]

Standard AVB Financial Corp. (NASDAQ: STND)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Standard AVB Financial Corp. (NASDAQ: STND) in connection with the proposed acquisition of the company by Dollar Mutual Bancorp.  Under the terms of the agreement, STND shareholders will receive $33.00 in cash for each share of STND common stock that they own.  If you own STND shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website:  https://weisslawllp.com/news/stnd/

Live Oak Acquisition Corp. (NYSE: LOAK)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Live Oak Acquisition Corp. (NYSE: LOAK) in connection with the company’s proposed merger with Danimer Scientific (“Danimer”).  Under the terms of the agreement, LOAK will acquire Danimer through a reverse merger that will result in Danimer becoming a publicly-traded company.  The transaction implies an equity value of $890 million for Danimer.  If you own LOAK shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/news/loak/

Mountain Crest Acquisition Corp. (NASDAQ: MCAC)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Mountain Crest Acquisition Corp. (NASDAQ: MCAC) in connection with the company’s proposed merger with Playboy Enterprises, Inc. (“Playboy”).  Under the terms of the agreement, MCAC will acquire Playboy through a reverse merger that will result in Playboy becoming a publicly-traded company.  The deal has an enterprise value of approximately $415 million.  If you own MCAC shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website:  https://weisslawllp.com/news/mcac/

LF Capital Acquisition Corp. (NASDAQ: LFAC)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of LF Capital Acquisition Corp. (NASDAQ: LFAC) in connection with the proposed acquisition of Landsea Homes Incorporated (“Landsea”).  Under the terms of the agreement, LFAC will acquire Landsea through a reverse merger that will result in Landsea becoming a publicly-traded company. Upon closing, Landsea’s founder, Landsea Green Properties Co., Ltd., will own 67.4% of the newly-combined company.  If you own LFAC shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website:  https://weisslawllp.com/news/lf-capital-acquisition-corp/

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-reminds-stnd-loak-mcac-and-lfac-shareholders-about-its-ongoing-investigations-301175435.html

SOURCE WeissLaw LLP

SHAREHOLDER ALERT: WeissLaw LLP Investigates Roth CH Acquisition I Co.

PR Newswire

NEW YORK, Nov. 17, 2020 /PRNewswire/ —

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Roth CH Acquisition I Co. (“ROCH” or the “Company”) (NASDAQ: ROCH) in connection with the Company’s proposed merger with PureCycle Technologies LLC (“PureCycle”), a privately-held plastics recycling company.  Under the terms of the merger agreement, ROCH will acquire PureCycle through a reverse merger that will result in PureCycle becoming a public company traded on the Nasdaq Capital Market under the new ticker symbol “PCT.”  The transaction has an implied enterprise value of approximately $826 million.


If you own ROCH shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, visit our website:


https://www.weisslawllp.com/ROCH/


Or please contact:



Joshua Rubin, Esq.

WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY  10036
(212) 682-3025
(888) 593-4771
[email protected]

WeissLaw is investigating whether ROCH’s board acted in the best interest of ROCH’s public stockholders in agreeing to the proposed transaction, whether the board was fully informed as to the valuation of PureCycle, and whether all information regarding the process undertaken by the board and the valuation of the transaction will be fully and fairly disclosed to ROCH public shareholders. 

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties.  We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases.  If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at [email protected]

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-investigates-roth-ch-acquisition-i-co-301175429.html

SOURCE WeissLaw LLP

Purpose Investments Inc. Announces November Distributions

TORONTO, Nov. 17, 2020 (GLOBE NEWSWIRE) — Purpose Investments Inc. is pleased to announce the following distributions for the month of November 2020. The ex-distribution date for all ETFs is November 24, 2020, with the exception of Purpose High Interest Savings ETF and Purpose US Cash Fund, which have an ex-distribution date of November 30, 2020. The ex-distribution date for all closed-end funds is November 27, 2020.   

Open-End Funds Ticker Symbol Distribution per share/unit Record Date Payable Date Distribution Frequency
Purpose Core Dividend Fund – ETF Series PDF $0.08501 11/25/2020 12/07/2020 Monthly
Purpose Enhanced Dividend Fund – ETF Series PDIV $0.05221 11/25/2020 12/07/2020 Monthly
Purpose Total Return Bond Fund – ETF Series PBD $0.05201 11/25/2020 12/07/2020 Monthly
Purpose Real Estate Income Fund – ETF Series PHR $0.07201 11/25/2020 12/07/2020 Monthly
Purpose Monthly Income Fund – ETF Series PIN $0.08301 11/25/2020 12/07/2020 Monthly
Purpose Premium Yield Fund – ETF Series PYF $0.08301 11/25/2020 12/07/2020 Monthly
Purpose Premium Yield Fund Non-Currency Hedged USD – ETF Series PYF.U US $ 0.08851 11/25/2020 12/07/2020 Monthly
Purpose Premium Yield Fund Non-Currency Hedged – ETF Series PYF.B $0.08851 11/25/2020 12/07/2020 Monthly
Purpose Canadian Financial Income Fund – ETF Series BNC $0.08501 11/25/2020 12/07/2020 Monthly
Purpose Conservative Income Fund – ETF Series PRP $0.05401 11/25/2020 12/07/2020 Monthly
Purpose Enhanced Premium Yield Fund – ETF Series PAYF $0.11811 11/25/2020 12/07/2020 Monthly
Purpose International Dividend Fund – ETF Units PID $0.0780 11/25/2020 12/07/2020 Monthly
Purpose US Dividend Fund – ETF Units PUD $0.0650 11/25/2020 12/07/2020 Monthly
Purpose US Dividend Fund Non-Currency Hedged – ETF Units PUD.B $0.0760 11/25/2020 12/07/2020 Monthly
Purpose Global Bond Fund – ETF Units BND $0.0585 11/25/2020 12/07/2020 Monthly
Purpose High Interest Savings ETF PSA $0.0272 11/30/2020 12/07/2020 Monthly
Purpose US Cash Fund PSU.U US$ 0.0285 11/30/2020 12/07/2020 Monthly
Purpose Strategic Yield Fund – ETF Units SYLD $0.0970 11/25/2020 12/07/2020 Monthly
Purpose Multi-Asset Income Fund – ETF Units PINC $0.0840 11/25/2020 12/07/2020 Monthly
Purpose Global Bond Class – ETF Units IGB $0.06021 11/25/2020 12/07/2020 Monthly
Purpose Canadian Preferred Share Fund – ETF Units RPS $0.0950 11/25/2020 12/07/2020 Monthly
Purpose Core Equity Income Fund – ETF Series RDE $0.06501 11/25/2020 12/07/2020 Monthly
Purpose US Preferred Share Fund – ETF Units RPU $0.0940 11/25/2020 12/07/2020 Monthly
Purpose US Preferred Share Fund Non-Currency Hedged – ETF Units2 RPU.B / RPU.U $0.0940 11/25/2020 12/07/2020 Monthly
Purpose Emerging Markets Dividend Fund – ETF Units REM $0.0580 11/25/2020 12/07/2020 Monthly
Purpose Floating Rate Income Fund – ETF Units FLOT $0.0297 11/25/2020 12/07/2020 Monthly
Purpose Floating Rate Income Fund – Non-Currency Hedged USD – ETF Units FLOT.U US$ 0.0375 11/25/2020 12/07/2020 Monthly
Purpose Floating Rate Income Fund – Non-Currency Hedged – ETF Units FLOT.B $0.0365 11/25/2020 12/07/2020 Monthly
           
Closed-End Funds Ticker Symbol Distribution

per share/unit
Record Date Payable Date Distribution Frequency
Investment Grade Managed Duration Income Fund – Class T PFU.UN $0.0417 11/30/2020 12/14/2020 Monthly
U.S. Banks Income & Growth Fund – Class T PUB.UN $0.0417 11/30/2020 12/14/2020 Monthly
Canadian Investment Grade Preferred Share Fund – Class T RIGP.UN $0.1146 11/30/2020 12/14/2020 Monthly
Big Banc Split Corp – Class A BNK $0.0662 11/30/2020 12/14/2020 Monthly
Big Banc Split Corp – Preferred Shares BNK.PR.A $0.0500 11/30/2020 12/14/2020 Monthly

(1) Dividend is designated as an “eligible” Canadian dividend for purposes of the Income Tax Act (Canada) and any similar provincial and territorial legislation.
(2) Purpose US Preferred Share Fund Non-Currency Hedged – ETF Units have both a CAD and USD purchase option. Distribution per unit is declared in CAD, however, the USD purchase option (RPU.U) distribution will be made in the USD equivalent. Conversion into USD will use the end-of-day foreign exchange rate prevailing on the ex-distribution date.

About Purpose Investments Inc.

Purpose Investments is an asset management company with more than $9 billion in assets under management. Purpose Investments has an unrelenting focus on client-centric innovation, and offers a range of managed and quantitative investment products. Purpose Investments is led by well-known entrepreneur Som Seif and is a division of Purpose Financial, an independent technology-driven financial services company.

For further information please contact:
Matt Padanyi
Purpose Investments Inc.
Tel: (877) 789-1517
Email: [email protected]

Commissions, trailing commissions, management fees and expenses all
may
be associated with investment fund investments. Please read the prospectus and other disclosure documents before investing. Investment funds are not covered by the Canada Deposit Insurance Corporation or any other government deposit insurer. There can be no assurance that the full amount of your investment in a fund will be returned to you. If the securities are purchased or sold on a stock exchange, you
may
pay more or receive less than the current net asset value. Investment funds are not guaranteed, their values change
frequently
and past performance
may
not be repeated.

 



WeissLaw LLP Reminds CXO, SRAC, and PIC Shareholders About Its Ongoing Investigations

PR Newswire

NEW YORK, Nov. 17, 2020 /PRNewswire/ —


If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:


Joshua Rubin, Esq.

WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY  10036
(212) 682-3025
(888) 593-4771
[email protected]

Concho Resources Inc. (NASDAQ: CXO)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Concho Resources Inc. (NASDAQ: CXO) in connection with the proposed acquisition of the company by ConocoPhillips (“COP”).  Under the terms of the acquisition agreement, CXO shareholders will be entitled to receive 1.46 shares of COP common stock for each share of CXO common stock that they own, representing implied per-share merger consideration of $55.60 based upon COP’s November 16, 2020, closing price of $38.08.  If you own CXO shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website:  https://weisslawllp.com/news/cxo/

Stable Road Acquisition Corp. (NASDAQ: SRAC)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Stable Road Acquisition Corp. (NASDAQ: SRAC) in connection with the company’s proposed merger with Momentus Inc. (“Momentus”).  Under the terms of the merger agreement, SRAC will acquire Momentus through a reverse merger that will result in Momentus becoming a publicly-traded company on the Nasdaq under the ticker symbol “MNTS.”  The transaction implies an equity value of $1.2 billion for Momentus on a pro forma basis.  If you own SRAC shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website:  https://weisslawllp.com/news/srac/

Pivotal Investment Corporation II (NYSE: PIC)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Pivotal Investment Corporation II (NYSE: PIC) in connection with the company’s proposed merger with privately-held XL Hybrids, Inc. (“XL Fleet”).  Under the terms of the merger agreement, PIC will acquire XL Fleet through a reverse merger that will result in XL Fleet becoming a publicly-traded company.  The transaction implies an enterprise value of $1 billion for XL Fleet on a pro forma basis.  If you own PIC shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website:  https://weisslawllp.com/news/pivotal-investment-corporation-ii/

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/weisslaw-llp-reminds-cxo-srac-and-pic-shareholders-about-its-ongoing-investigations-301175427.html

SOURCE WeissLaw LLP

AWS Announces General Availability of AWS Network Firewall

AWS Announces General Availability of AWS Network Firewall

New high-availability firewall service gives customers added visibility and control to easily secure their virtual networks running on AWS

GE and the U.S. Navy among the customers using AWS Network Firewall

SEATTLE–(BUSINESS WIRE)–
Today, Amazon Web Services Inc., an Amazon.com company (NASDAQ: AMZN), announced the general availability of AWS Network Firewall, a new managed security service that makes it easier for customers to enable network protections across all of their AWS workloads. Customers can enable AWS Network Firewall in their desired Amazon Virtual Private Cloud (VPC) environments with just a few clicks in the AWS Console, and the service automatically scales with network traffic to provide high availability protections without the need to set up or maintain the underlying infrastructure. AWS Network Firewall’s flexible rules engine gives customers granular control to define their own custom rules or integrate with their existing security ecosystem by importing rules from leading AWS Partner Network (APN) security partners like AlertLogic, CrowdStrike, Fortinet, and Trend Micro. There are no additional charges or upfront commitments required to use AWS Network Firewall, and customers pay only by hours deployed and gigabytes processed. To get started with AWS Network Firewall, visit https://aws.amazon.com/network-firewall/.

AWS provides comprehensive protections to help customers secure their networks, such as AWS Web Application Firewall (WAF) to protect internet-facing web applications, AWS Shield to safeguard against Distributed Denial of Service (DDoS) attacks, and AWS Firewall Manager which provides central management and visibility across all firewall controls on AWS. While these and other protections combine to provide highly secure and flexible layers of defense, many customers also want a simple way to apply and manage blanket network protections across all of their workloads (e.g., domain-based access controls, monitoring to identify malicious traffic patterns, and unified traffic inspection spanning from the network layer to the application layer). Customers also want to customize these protections based on their organization’s specific security needs, import rules from other trusted providers that they already use, and easily integrate collected logs and network data into their existing security workflows. Customers are seeking easy-to-use and customizable network protections, without having to manually patch and maintain servers, handle failover, and provision capacity.

With AWS Network Firewall, customers can easily deploy granular network protections across their entire AWS environment, without the need to configure and manage additional security infrastructure. AWS Network Firewall provides essential protections against common network threats, including dynamic packet filtering, intrusion prevention and detection, and web filtering. Customers can also implement customized Snort and Suricata rules (two widely used open source formats) to further tailor protections like preventing their VPCs from accessing unauthorized domains, blocking thousands of known bad IP addresses, or defending against common exploits by identifying patterns and behaviors associated with known threats. Customers can monitor firewall activity in real time via Amazon CloudWatch metrics, and can have AWS Network Firewall automatically send network traffic logs to Amazon Simple Storage Service (S3), Amazon Cloudwatch, and Amazon Kinesis Data Firehose for additional visibility and auditing purposes.

“When we talk to customers about what they want in a cloud network firewall they tell us that they want network protections that work with their existing security systems and without the headache of managing the underlying infrastructure,” said Steve Schmidt, CISO, AWS. “AWS Network Firewall provides scalable network protections that allow customers to deploy highly customizable rules for their entire AWS infrastructure, and integrates with many of the APN partner services that customers already use. Best of all, there’s no need to configure or maintain additional infrastructure.”

AWS Network Firewall integrates with AWS Firewall Manager, allowing customers to build policies based on AWS Network Firewall rules and centrally apply those policies across their VPCs and accounts through the AWS Firewall Manager Console and API. Leading providers, including Accenture, Alert Logic, Check Point Software Technologies, CrowdStrike, Datadog, Fortinet, Hashicorp, IBM, Palo Alto Networks, Rackspace, Splunk, SumoLogic, Trend Micro, and Tufin have built integrations with AWS Network Firewall, with more coming soon. These integrations allow customers to easily incorporate AWS Network Firewall into their existing security workflows for orchestration, automation, and threat detection and response. AWS Network Firewall is available today in the US East (N. Virginia), US West (Oregon), and Europe (Dublin) regions, with more regions coming soon.

For more than 125 years, GE has invented the future of industry. “We have a high bar for security at GE, which means we dedicate a considerable amount of time and resources to network protection across our sizeable cloud footprint,” said Matthew Green, Sr. Director of Cloud Architecture, GE. “AWS Network Firewall will continue to keep GE on the bleeding edge of cloud technology and afford us the opportunity to utilize best-in-class firewalling and threat detection to protect our egress traffic across all our workloads.”

The U.S. Navy Sea Warrior Program’s mission is to rapidly identify and implement affordable IT solutions. After testing AWS Network Firewall’s scalability and functionality, the US Navy agrees that the service meets the needs of the program. “The U.S. Navy Sea Warrior Program (PMW 240) has a requirement for cybersecurity as a service and is testing options within an Other Transaction Authority (OTA) contract vehicle awarded to AWS via the IWRP OTA,” said a representative from Navy PMW 240 Sea Warrior. “PMW 240 requires a cybersecurity solution that automates firewall infrastructure, scale, and performance to allow it to better focus on cyber alerts and protection of Navy data.”

Fortinet secures the largest enterprise, service provider, and government organizations around the world. “Fortinet’s work with cloud customers of all shapes and sizes gives us broad visibility into the most critical components of network security in the cloud,” said John Maddison, EVP of Products and CMO at Fortinet. “We’ve made this expertise available to all AWS Network Firewall customers in the form of managed rules based on threat intelligence from FortiGuard Labs. Our collaboration with AWS will make it easy for customers to seamlessly integrate Fortinet threat intelligence with AWS Network Firewall as an additional layer of protection alongside their existing security.”

Rackspace Technology is a leading end-to-end multicloud technology services company. “At Rackspace we have a long history of supporting small and midsize businesses in their journey to the cloud, and one of the most common challenges these customers face is finding a simple and accessible way to secure their network and web applications,” said Aaron Hackney, Principal Architect of Network Security, Rackspace Technology. “Existing solutions are often either exclusively aimed at big enterprises and thus too costly and complex, or too bare bones to be truly effective without a lot of customization and additional development. AWS Network Firewall gives these customers powerful protections against common network threats without requiring existing security expertise or piles of money just to get started.”

About Amazon Web Services

For 14 years, Amazon Web Services has been the world’s most comprehensive and broadly adopted cloud platform. AWS offers over 175 fully featured services for compute, storage, databases, networking, analytics, robotics, machine learning and artificial intelligence (AI), Internet of Things (IoT), mobile, security, hybrid, virtual and augmented reality (VR and AR), media, and application development, deployment, and management from 77 Availability Zones (AZs) within 24 geographic regions, with announced plans for 15 more Availability Zones and five more AWS Regions in India, Indonesia, Japan, Spain, and Switzerland. Millions of customers—including the fastest-growing startups, largest enterprises, and leading government agencies—trust AWS to power their infrastructure, become more agile, and lower costs. To learn more about AWS, visit aws.amazon.com.

About Amazon

Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. Customer reviews, 1-Click shopping, personalized recommendations, Prime, Fulfillment by Amazon, AWS, Kindle Direct Publishing, Kindle, Fire tablets, Fire TV, Amazon Echo, and Alexa are some of the products and services pioneered by Amazon. For more information, visit www.amazon.com/about and follow @AmazonNews.

Amazon.com, Inc.

Media Hotline

[email protected]

www.amazon.com/pr

KEYWORDS: Washington United States North America

INDUSTRY KEYWORDS: Banking Software Networks Professional Services Online Retail Internet Hardware Data Management Technology Small Business Security Retail Finance

MEDIA:

Logo
Logo